Form 8-K PRINCIPAL FINANCIAL GROU For: Jul 24
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140724/A5U2F22CP222V2Z2222Q2MZZ4UQG42H23262
Filed on: July 24, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Principal Asset Management® Launches Fixed Income ETF Suite
- Torex Semiconductor Has Achieved "Zero" Current Consumption with Multi-Function Load Switch ICs XC8115/XC8116 Series
- Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
